ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 177 filers reported holding ARCUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $32,741,284 | 17.51% |
| Octagon Capital Advisors LP | 1,968,000 | $39,970,080 | 5.56% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $17,665,435 | 5.54% |
| Logos Global Management LP | 750,000 | $15,232,500 | 2.07% |
| Boxer Capital, LLC | 1,602,200 | $32,541 | 1.51% |
| DAFNA Capital Management LLC | 225,717 | $4,584,312 | 1.25% |
| SECTORAL ASSET MANAGEMENT INC | 354,490 | $7,199,692 | 1.20% |
| PFM Health Sciences, LP | 1,405,056 | $28,536,687 | 1.11% |
| Ikarian Capital, LLC | 280,000 | $5,686,800 | 0.91% |
| Ikarian Capital, LLC | 200,000 | $4,062,000 | 0.65% |